Epigenetics as a versatile regulator of fibrosis

J Transl Med. 2023 Mar 2;21(1):164. doi: 10.1186/s12967-023-04018-5.


Fibrosis, a process caused by excessive deposition of extracellular matrix (ECM), is a common cause and outcome of organ failure and even death. Researchers have made many efforts to understand the mechanism of fibrogenesis and to develop therapeutic strategies; yet, the outcome remains unsatisfactory. In recent years, advances in epigenetics, including chromatin remodeling, histone modification, DNA methylation, and noncoding RNA (ncRNA), have provided more insights into the fibrotic process and have suggested the possibility of novel therapy for organ fibrosis. In this review, we summarize the current research on the epigenetic mechanisms involved in organ fibrosis and their possible clinical applications.

Keywords: Chromatin remodeling; DNA methylation; Epigenetics; Fibrosis; Histone modification; Noncoding RNA.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Methylation* / genetics
  • Epigenesis, Genetic*
  • Extracellular Matrix / genetics
  • Humans
  • Protein Processing, Post-Translational
  • Research Personnel